Therapy with mitoxantrone, ifosfamide, vindesine, and prednisolone for malignant lymphoma with adjustable doses and timing of courses.
Thirty-seven patients with malignant lymphoma were treated with mitoxantrone, ifosfamide, vindesine, and prednisolone. The time among courses was not fixed, being decided by the time for recovery from the leukopenia caused by the treatment. The drug dose was adjusted after the initial course. Of the 12 patients treated for the first time, eight had a complete remission and two had a partial response. Of the 18 patients who relapsed after another drug regimen, six had a complete remission and seven had a partial response. The SD of the leukocyte nadirs decreased after the first course, and time needed for recovery from leukopenia tended to shorten during treatment. Side effects seemed mild, and we can use many drugs safely in a short term without long drug-free intervals. Response rates were satisfactory, compared with other report, so this method of timing the start of courses with adjustment of the dose seems useful.
Inoue
T
T
Department of Laboratory Medicine, Osaka City University Medical School, Japan.
Furukawa
Y
Y
Yamane
T
T
Hiyoshi
M
M
Sasaki
A
A
Kishida
T
T
Park
K
K
Im
T
T
Tatsumi
N
N
Okuda
K
K
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007958:Leukocyte Count / Q000187:drug effects; D008223:Lymphoma / Q000097:blood / Q000188:drug therapy*; D008942:Mitoxantrone / Q000008:administration & dosage; D014751:Vindesine / Q000008:administration & dosage
D008942:Mitoxantrone; D014751:Vindesine; D007069:Ifosfamide